Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bicifadine SR in diabetic peripheral neuropathic pain
2007-003638-40Phase 2Completed
- Sponsor
- XTL Biopharmaceuticals Ltd.
- Start
- Oct 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of bicifadine in diabetic polyneuropathy (DPN) and Neuralgia (3 arms), sponsored by XTL Biopharmaceuticals Ltd. Primary endpoint: Change from baseline to Week 14 in weekly mean PI-NRS score. Started Oct 2007; status: completed.
02
Drugs
bicifadine
03
Conditions
diabetic polyneuropathy (DPN)Neuralgia
Beyond the preview
Go deeper on 2007-003638-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003638-40.